Skip to main content

Industrial Microbiology Market is expected to grow at a CAGR of 8.36%

 The capability of genetically engineered cells to make new products revolutionized the processes of industrial microbiology. Techniques like gene mounting and genetic engineering have helped the fermentation industry with enhanced productivity. The use of bioprocesses helped the industries to deliver fine-quality products. The application of industrial microbiology is currently expanding in areas such as therapeutics, diagnostics, environmental protection, mineral recovery, and agriculture, apart from its traditional application in the food and beverage industry.

The global industrial microbiology market was valued to be $5,604.2 million in 2019 and is expected to reach $13,181.2 million by 2030, witnessing a CAGR of 8.36% during the forecast period 2020-2030. The market growth can mainly be attributed to the growing research in the field of industrial microbiology, increasing awareness among researchers about new strains of microorganisms, rise in preference toward consumer products, increase in research and development as well as collaborations in pharmaceutical and biotechnology industries, and use of rapid sterility testing methods for pathogen detection.

The global industrial microbiology market is currently dominated by Thermo Fisher Scientific, followed by bioMérieux SA. The market dominance of Thermo Fisher Scientific can be attributed to a large product portfolio for automated microbial detection systems. bioMérieux SA held the second largest market share in the industrial microbiology market, attributed to its significant contribution in the field. The company offers a wide range of products to be utilized for industrial procedures in the biopharmaceutical, food and beverages, and water industry. Merck KGaA holds the third largest share, owing to its diverse range of product offerings in consumables (including media, detection kits, and accessories) and detection systems. Other prominent players, namely, 3M, BD, Bio-Rad Laboratories, Inc., bioMérieux SA, Charles River Laboratories International, Inc., Pall/Danaher Corporation, Merck KGaA, and Eppendorf, collectively hold a large market share of the total global industrial microbiology market in 2019.

Based on region, North America is the leading contributor to the industrial microbiology market in terms of revenue. The fields such as commercial quality assurance and biotechnology & pharmaceutical companies are expected to progress at significant rates, and the substantial investments made in these fields are consequentially promoting the growth of the North America industrial microbiology market. However, the Asia-Pacific and Europe regions, constituting several emerging companies contributing to industrial microbiology, are expected to register the high CAGR during the forecast period of 2020-2030.

Request  a Sample - https://bisresearch.com/requestsample?id=1074&type=download

Labels:

Comments

Post a Comment

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...
Post a Comment
Read more

Digital PCR Market size,Share, Leading Players, Growth, Development and Demand Forecast to 2032

  Increasing investments in R&D for d-PCR molecular diagnostics is one of the major opportunities in the global digital PCR market. Several biotechnology and life sciences companies are working collaboratively on diagnostic test development and using d-PCR as a therapeutic means for applications in several disease indications to enable efficient diagnosis, treatment selection, and treatment monitoring. The global  digital PCR market   is projected to reach $2,847.8 million by 2032 from $441.2 million in 2021, at a CAGR of 18.73% during the forecast period 2022–2032. The growth in the global digital PCR market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases globally, the rising awareness of d-PCR-based diagnostic testing, and the significant number of funding for executing research and development. Impact of COVID-19 The current global digital PCR market comprises kits and assays, system, and reagents and consuma...
Post a Comment
Read more

Radiation Dose Management Market Likely To Increase Size, Shares, And Demand Forecast 2022-2032

  Radiation dose is the amount of radiation absorbed by a patient during a diagnostic imaging procedure. A large dose of radiation can cause tissue damage and increase the risk of developing cancer in later stages of life.The development of on-cloud dose management solutions and the growing initiatives on radiation dose management for pediatric procedures are some of the major opportunities in the global radiation dose management market. Furthermore, some of the key trends going on in the market include the increasing development of imaging modalities with technologies that lower radiation dose, partnerships and strategic business alliances dominating the market, and various collaborations among market players. The global  radiation dose management market   was valued at $212.8 million in 2021 and is anticipated to reach $586.7 million by 2032, witnessing a CAGR of 10.30% during the forecast period 2022–2032. The growth in the global radiation dose management market is ex...
Post a Comment
Read more